Abstract 5336
Background
Lung cancer stem cells (CSCs) are a small subpopulation of cells with self-renewal, tumorigenic properties and the ability to grow to form tumorspheres in non-adherent conditions. Recently, the study on soluble molecules has been a new focus to understand the interaction between CSCs and tumor microenvironment. The aim of this work is to compare the release of cytokines between monolayer cells and tumorspheres of NSCLC cultures.
Methods
The study was performed on medium supernatant of cells from 8 NSCLC tumour patients samples and 10 cell lines (A549, H1650, H460, H23, H358, H2228, HCC827, PC9, H1993, SW900) grown in monolayer and tumorspheres at 2 different densities (104 and 105 cells/ml); supernatant was recollected at 12h and 24h. We analyzed 8 soluble factors with immunosuppressive (IL-4, IL-10, IL-13), and immunoregulatory (IL-6, IL-8, IL-17A, TNFa, IFN) capacity through sensitivity bead-based multiplex assay using the Millipore kit from the Luminex 100/200.
Results
IL-4, IL-6, IL-8, TNFa levels were detected in all samples while IFN, IL-10, IL-13, IL-17A were beyond the detectable range in adherents for most of cultures (Detection range [pg/ml] of IL-4: 1.83-7497.38, IL-6: 0.18-813.66, IL-8: 0.31-1042.75, TNFa: 0.43-1758.47, IFN: 0.61-2468.39, IL-10: 1.46-6056.85, IL-13: 0.24-1002.76, IL-17A: 0.73-3074.88). We observed significant differences in levels of IL-6, IL-13, IL-17A, TNFa, IFN between adherent cells and tumorspheres. Moreover, IL-4, IL-10, IL-13, IL-17A, IFN levels in tumorspheres were higher than monolayer. Otherwise, IL-6 and TNFa were secreted more in monolayer. IL-8 is the most secreted molecule in both adherents and tumorspheres by all cultures.
Conclusions
Our preliminary results suggest that high levels of IL-6 and IL-8 were detected in all samples. IL-8, IL-13, IL-17A and IFN secreted by lung CSCs could be involved in the modulation of the immune microenvironment. Additionally, adherent cells show increased levels of IL-6 and TNFa compared to tumorspheres, and IL-8, IL-4, IFN, IL-10, IL-13, IL-17A show the opposite. The next is to extend the cohort to validate our results and to study others immunoregulatory factors. Supported by grants from FEDER and PI12-02838 and PI15-00753 from ISCIII.
Clinical trial identification
Legal entity responsible for the study
Fundación de Investigación del Hospital General Universitario de Valencia.
Funding
Supported by grants from FEDER and PI12-02838 and PI15-00753 from ISCIII.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
3816 - A prediction panel with DNA methylation biomarkers for lung adenocarcinoma
Presenter: Nan Shen
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5242 - Novel genomic classifier for early stage colorectal cancer patients
Presenter: Elisabeth Letellier
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5404 - Baseline Blood Immune Profiling to Predict Response to antiPD-1 in Patients with Advanced Non-Small Cell Lung Cancer
Presenter: Emanuela Romano
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5462 - Evaluation of clinicopathological and molecular criterias for screening of exonucleasic domain POLE (edPOLE) mutated patients in proficient Mismatch Repair (pMMR) colorectal and endometrial cancers.
Presenter: Justine Cohen
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5465 - Immune prognostic index (IPI) and Hyper-Progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in Phase 1 trials (Ph1T): can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?
Presenter: Ignacio Matos Garcia
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5742 - Combination of baseline LDH, performance status and age to identify solid tumor patients with higher probability of response to anti-PD1 and PDL1 monoclonal antibodies
Presenter: Maria Silvia Cona
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5790 - Effects of concomitant genetic alterations on cancer patient overall survival
Presenter: Yu Wang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5144 - Circulating Exosomal Integrin _v_5 Predicts Liver Metastasis and Prognosis in Human Colorectal Cancer
Presenter: Dake Chu
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5149 - Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for Non-Small Cell Lung Cancer patients?
Presenter: Rosalinda Sorrentino
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5673 - Smokers and COPD patients have high circulating caspase-4 levels: is it an alarm?
Presenter: Michela Terlizzi
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract